Navigation Links
A new therapy without side effects could improve dramatically chemotherapy
Date:7/19/2011

Researchers of the University of Granada and Edimbourgh have developed a new therapy for cancer based on nanotechnology that might improve significantly chemotherapy, as it has not cause side effects.

This therapy is based on the encapsulation of a catalyst (palladium) into microspheres, to synthesize artificial materials or activate drugs within human cells, thus avoiding any toxicity. This system captures palladium within its microstructure. Palladium is a metal not found naturally in human cells that allows to catalyze chemical reactions within cells without altering its basic functions such as protein synthesis and metabolism. This technique allows to "create" anti-cancer drugs within cells, which could be used for the specific treatment of tumors and would improve dramatically current chemotherapy treatments.

The results of this research conducted in collaboration with the University of Kebangsaan (Malasia) were recently published in the prestigious journal Nature Chemistry.

Participation Of The University of Granada

Rosario Mara Snchez Martn the researcher that has developed this technology at the School of Chemistry of the University of Edimbourgh has recently joined the Department of Pharmaceutical and Organic Chemistry of the University of Granada.

Another of the scientists that forms this research group, Asier Unciti Broceta, did his undergraduate studies and doctorate at the Department of Pharmaceutical and Organic Chemistry at the University of Granada, and he currently continues his successful career in Edinburgh, where he was recently named Fellow of the Edinburgh Cancer Research UK Centre, and received the award of Young Life Scientist of the Year 2010 in Scotland. Additionally, he has founded a new company, Deliverics Ltd, based on one of his patents.

Researchers pointed that, given the wide range of therapeutic applications of nanotechnology, this research will be further developed by University of Granada professor Dr Sanchez Martin, who will continue her collaboration with the research group conducted by professor Mark Bradley of the University of Edimbourgh.


'/>"/>

Contact: Rosario Mara Snchez Martn
rmsanchez@ugr.es
0034-958-246-678
University of Granada
Source:Eurekalert

Related medicine news :

1. New therapy provides hope for millions of people suffering from bowel incontinence
2. Novel combined therapy extends life, diminishes pain in brain cancer patients
3. Virtual Reality May Help in Parkinsons Therapy
4. Mainz University Medical Center deploys new system for therapy of metastatic spinal tumors
5. Special Talk Therapy Seems to Help Dying Patients
6. New Combo Therapy May Prevent TB, Save Lives in People With HIV
7. Experiment aboard shuttle Atlantis will test novel therapy to build bone during space travel
8. High EGFR expression a predictor for improved survival with cetuximab plus chemotherapy
9. EURTAC Phase III study: Erlotinib nearly doubles progression-free survival vs. chemotherapy
10. New therapy for childhood neuroblastoma proves feasible and safe
11. Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... ... Emergency rooms provide emergency care to stabilize critical health issues, but emergency ... emergencies at risk of losing a tooth or their smiles. Dr. Marine Martirosyan, ... emergencies include:, , Avulsed or knocked-out teeth , ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... bring together more than 200 of the country’s top healthcare executives to share ... “The true benefit of the Forum is the provider-centric perspective, experience, expertise and ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The ... and inspirational speaker Jan Fox will serve as keynote speaker at the organization’s ... participants with tools to more effectively communicate with their own organizational staff and ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... digital self-scheduling readily available to physicians. The integration will enable Allscripts users ... select appointments via Everseat’s free mobile app. , The partnership gives Everseat substantial ...
(Date:2/10/2016)... , ... February 10, 2016 , ... The recreational use ... enthusiasts in the state still face a lot of restrictions as to where they ... intended for private, personal use” and that cannabis “may not be consumed openly or ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016 CSI Specialty Group (CSI) expanded its ... the Specialty Pharmacy Podcast. A free, weekly show, the ... real-world education, discussion and context amongst specialty pharmacy peers ... --> The Specialty Pharmacy Podcast, hosted by ... Group Suzette DiMascio, CHE, CMCE, CPC, is available for ...
(Date:2/10/2016)... Switzerland and SAN DIEGO ... , Inc., a global leader in viral gene therapy ... therapy treatments for congestive heart failure and other chronic ... develop a scalable manufacturing process and produce cGMP-grade RT-100 ... trials. --> --> ...
(Date:2/10/2016)... Feb. 10, 2016 Urologix, the market leader ... of Benign Prostatic Hyperplasia (BPH), announces new private ownership ... , a medical device industry veteran of more than ... Liability Company.  Plymouth, Minn. ... Cooled ThermoTherapy™ and Prostiva® RF Therapy, will continue to ...
Breaking Medicine Technology: